Latest / The Well-Built Life / Metabolic Insights: Understanding Insulin & Diabetes
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:06Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:13Speaker 1: share simple practical habits that help you feel stronger, healthier,
- 0:17Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:22Speaker 1: and let's dive in. All right, Thomas, let's dive into
- 0:25Speaker 1: the nuts and bolts of diabetes and insulin regulation. How
- 0:30Speaker 1: does it all work under the hood, you know, from
- 0:33Speaker 1: a physiological standpoint?
- 0:34Speaker 2: Absolutely, Rachel. Let's start with the basics. The human body
- 0:38Speaker 2: circulates about 5 liters of blood, and in a healthy individual,
- 0:42Speaker 2: normal blood glucose levels hover around 4.5 grams per 5 liters,
- 0:48Speaker 2: essentially a teaspoon. This balance is crucial, and it's maintained
- 0:53Speaker 2: mainly through insulin, a hormone produced by the pancreas.
- 0:56Speaker 1: That's the sweet spot, right? Now, as we consume more
- 1:00Speaker 1: refined carbs, our bodies can start to struggle with this balance.
- 1:05Speaker 1: I have read that the average intake is around 60
- 1:07Speaker 1: to 65 teaspoons daily. This can lead to something called
- 1:11Speaker 1: insulin resistance, where the body has to produce more insulin
- 1:15Speaker 1: to manage the excess sugar.
- 1:17Speaker 2: Exactly, and that's the starting point for a lot of
- 1:20Speaker 2: metabolic issues. Over time, the pancreas goes into overdrive. producing
- 1:25Speaker 2: more and more insulin in response to the high blood sugar.
- 1:29Speaker 2: This is especially concerning when we start seeing fasting insulin
- 1:32Speaker 2: levels consistently above 5 microunits per illiliter. At 8 to
- 1:38Speaker 2: 15 microunits per milliliter, people are already at high risk,
- 1:42Speaker 2: and above 15, it's a serious health concern.
- 1:45Speaker 1: Right. And to raise this interesting nuance in regional differences,
- 1:50Speaker 1: for example, in the United States, The range for normal
- 1:53Speaker 1: fasting insulin levels is 2.6 to 24.9 microunits per milliliter,
- 2:00Speaker 1: whereas in the UK, it's 2.0 to 25. This variability
- 2:04Speaker 1: complicates diagnoses, doesn't it?
- 2:07Speaker 2: Indeed, it highlights the lack of a universal standard for
- 2:10Speaker 2: normal insulin levels. About 40% of the population within these
- 2:14Speaker 2: normal ranges actually experience insulin resistance. This implies that the
- 2:19Speaker 2: current thresholds might be broader and less stringent than what's
- 2:22Speaker 2: actually optimal for preventing long-term health issues.
- 2:25Speaker 1: That's a critical point. Healthcare providers, especially those focused on
- 2:30Speaker 1: lifestyle and longevity, often target fasting insulin levels below 5
- 2:34Speaker 1: microunits per mL. But the real challenge is frequent and
- 2:38Speaker 1: precise testing to monitor trends and interventions.
- 2:41Speaker 2: Exactly. And from a critical perspective, we need to look
- 2:45Speaker 2: at the full spectrum. For instance, AAC tests provide long-term
- 2:49Speaker 2: glucose assessment, but they don't directly reflect current insulin regulatory status.
- 2:55Speaker 2: This is where interventions like intermittent fasting and mindful dietary
- 2:59Speaker 2: adjustments can play a significant role in promoting overall metabolic health.
- 3:04Speaker 1: And yet, the variability in laboratory results adds another layer
- 3:08Speaker 1: of complexity. With a noted 66% discrepancy between different testing facilities,
- 3:15Speaker 1: It's clear that standardizing these protocols is crucial. We can't
- 3:19Speaker 1: just rely on broad regional definitions when diagnosing and managing
- 3:24Speaker 1: these conditions.
- 3:25Speaker 2: Precisely. This underscores the need for a multifaceted approach to
- 3:30Speaker 2: diabetes and insulin regulation. It's not just about thresholds and ranges,
- 3:35Speaker 2: but about integrating multiple diagnostic tools for comprehensive management. In
- 3:40Speaker 2: the future, I foresee digital health solutions and personalized medicine
- 3:44Speaker 2: approaches taking center stage, tailoring wellness plans based on genetic
- 3:49Speaker 2: and epigenetic factors to enhance the efficacy of lifestyle modifications.
- 3:53Speaker 1: So, let's dive into how insulin manages the dance of
- 3:56Speaker 1: blood sugar levels. Think of it as a finely tuned orchestra.
- 4:00Speaker 1: Insulin is the conductor. Glucose is the melody, and the
- 4:04Speaker 1: cells are the musicians. With each meal, our pancreas sends
- 4:07Speaker 1: out a measured dose of insulin to guide glucose into
- 4:10Speaker 1: cells for energy.
- 4:11Speaker 2: Exactly. And just like an overzealous conductor or a room
- 4:15Speaker 2: full of sleepy musicians, insulin can become less effective. When
- 4:19Speaker 2: this happens, it's a sign of insulin resistance, where the
- 4:23Speaker 2: body's cells don't respond as strongly to insulin. This is
- 4:26Speaker 2: like the musicians tuning their instruments but still producing a
- 4:29Speaker 2: muffled sound. Right.
- 4:32Speaker 1: This can be a gradual process, especially with a diet
- 4:35Speaker 1: high in refined carbs. Over time, the pancreas tries to
- 4:40Speaker 1: compensate by pumping out more insulin, much like the conductor
- 4:44Speaker 1: raising the tempo to keep the music flowing. But eventually,
- 4:48Speaker 1: this overproduction can lead to wear and tear, much like
- 4:51Speaker 1: the conductor getting too worked up and losing their composure. Wild. So,
- 4:56Speaker 1: these ranges aren't just broad. They might be too inclusive.
- 5:01Speaker 1: This complicates things for healthcare providers and patients. Take, for instance,
- 5:06Speaker 1: someone who falls right within the typical U.S. range. They
- 5:10Speaker 1: might be in a healthier state, or they might be
- 5:12Speaker 1: teetering on the verge of trouble.
- 5:14Speaker 2: Precisely. It's like a Goldilocks situation. Too high, too low,
- 5:19Speaker 2: or just right. But even with these nuances, Tereza threshold
- 5:23Speaker 2: for concern. If fasting insulin levels are over 5 microunits
- 5:28Speaker 2: per m-illiliter, We are talking about early signs of insulin resistance.
- 5:32Speaker 2: Levels between 8 and 15 are a red flag, and
- 5:36Speaker 2: anything above 15 is a warning sign.
- 5:39Speaker 1: So, it's not just about fasting levels either. Other factors
- 5:43Speaker 1: come into play, like the tests themselves. Different laboratories can
- 5:47Speaker 1: yield results that vary by 66%, which is staggering. It's
- 5:51Speaker 1: like trying to measure the same cup of coffee with
- 5:54Speaker 1: different spoons. This variability underscores the need for standardized protocols.
- 5:59Speaker 1: and perhaps even more precise testing techniques.
- 6:01Speaker 2: Absolutely. And it's not just about accuracy. It's about providing
- 6:05Speaker 2: tools that are readily accessible. For example, intermittent fasting and
- 6:10Speaker 2: mindful dietary adjustments can make a big difference. But when
- 6:14Speaker 2: it comes to personalized care, it's all about finding the
- 6:17Speaker 2: right balance. This is where digital health solutions and personalized
- 6:22Speaker 2: medicine come in. Tailoring plans based on genetic and epigenetic factors. Yes.
- 6:28Speaker 1: And this holistic approach is key. It's about more than
- 6:32Speaker 1: just reducing insulin levels. It's about understanding the whole ecosystem
- 6:36Speaker 1: of health. The real value lies in pinpointing at-risk individuals
- 6:41Speaker 1: early on and providing them with actionable, personalized guidance.
- 6:46Speaker 2: Exactly. And this is where we see the future diagnostic
- 6:50Speaker 2: tools that are not just reactive but predictive. By integrating
- 6:54Speaker 2: genetics and lifestyle data. we can create a much more
- 6:57Speaker 2: precise picture of metabolic health, potentially transforming how we approach
- 7:02Speaker 2: prevention and management.
- 7:03Speaker 1: The challenge with current fasting insulin ranges is that they
- 7:06Speaker 1: don't always capture the full spectrum of metabolic health. Imagine
- 7:10Speaker 1: a seesaw. On one side, we have the risk of
- 7:13Speaker 1: high fasting insulin levels leading to insulin resistance. On the other,
- 7:18Speaker 1: some individuals may have lower fasting insulin levels, but still
- 7:21Speaker 1: experience issues due to other factors.
- 7:23Speaker 2: Exactly. And this is where the AC test comes in
- 7:27Speaker 2: as a crucial complement. It offers a broader view by
- 7:30Speaker 2: looking at average blood glucose levels over two to three months.
- 7:35Speaker 2: But it's not without its limitations. For instance, it doesn't
- 7:38Speaker 2: account for short-term fluctuations, which can be significant in certain individuals. Right.
- 7:44Speaker 1: And that's the crucial nuance here. The combination of fasting
- 7:47Speaker 1: insulin and ASCC provides a more holistic picture. Let's take
- 7:52Speaker 1: the UK as an example. Their Ardernine to Arshawool Unicronate's
- 7:56Speaker 1: per milliliter range is broader than the U.S., yet it
- 8:00Speaker 1: still misses the mark for precision.
- 8:02Speaker 2: True. And remember, even with these ranges, a healthy individual
- 8:06Speaker 2: might have slightly higher fasting insulin levels due to various factors.
- 8:11Speaker 2: For instance, a higher body mass index or stress can
- 8:15Speaker 2: raise levels, skewing the results.
- 8:17Speaker 1: Speaking of stress, it's a double-edged sword. Chronic stress can
- 8:21Speaker 1: increase insulin levels. But paradoxically, it also affects the axi
- 8:26Speaker 1: measurement because it impacts overall blood glucose variance. This variability
- 8:31Speaker 1: makes it harder to interpret the data accurately.
- 8:34Speaker 2: That's a great point. So, what are we missing in
- 8:37Speaker 2: our current models? Therese, a push for more personalized benchmarks now.
- 8:42Speaker 2: Think of it like customized fitness plans. Why not tailor
- 8:45Speaker 2: insulin management too? This could involve integrating lifestyle, diet, and
- 8:50Speaker 2: genetic factors.
- 8:51Speaker 1: Absolutely. Integrating all these factors would bring us closer to
- 8:55Speaker 1: understanding individual metabolic needs. For instance, someone with a genetic
- 9:00Speaker 1: predisposition might require a different fasting insulin threshold compared to
- 9:06Speaker 1: a healthy lifestyle individual.
- 9:07Speaker 2: Exactly, which brings up an interesting contradiction. While we are
- 9:12Speaker 2: trying to be more precise, the reality is we need
- 9:15Speaker 2: more standardized testing protocols and tools. For someone trying to
- 9:20Speaker 2: manage their health, the lack of clear, consistent guidelines can
- 9:24Speaker 2: be frustrating. True.
- 9:25Speaker 1: And this is where digital health solutions come in. Imagine
- 9:29Speaker 1: having an app that could adjust fasting insulin thresholds based
- 9:33Speaker 1: on real-time data and individual genetic profiles. It could recommend
- 9:37Speaker 1: lifestyle changes that not only optimize insulin levels, but also
- 9:41Speaker 1: enhance overall well-being.
- 9:43Speaker 2: That's wild when you look at the raw numbers, with
- 9:46Speaker 2: the right tools and data. We could potentially reduce the
- 9:49Speaker 2: prevalence of diabetes and other metabolic issues. It's about moving
- 9:53Speaker 2: from reactive medicine to a proactive and personalized approach. Right.
- 9:57Speaker 1: So let's delve into the quotes from experts. Take the
- 10:00Speaker 1: one that says, If your fasting insulin is between 5
- 10:03Speaker 1: and 8, you have already started to develop some insulin resistance.
- 10:08Speaker 1: It's not majorly severe, but it's still too high. What
- 10:12Speaker 1: do you think that means for our listeners, Thomas?
- 10:14Speaker 2: Exactly. High fasting insulin levels, even modest ones, can set
- 10:19Speaker 2: the stage for bigger issues down the line. It's a
- 10:22Speaker 2: bit like a warning signal. Your body's trying to tell
- 10:24Speaker 2: you something. That quote highlights that maintaining those levels, especially
- 10:29Speaker 2: between 5 and 8 microunits per m-illiter, isn't necessarily optimal.
- 10:35Speaker 2: It's a reminder that we need to pay attention to
- 10:37Speaker 2: our insulin levels and not just wait for them to spike.
- 10:41Speaker 1: Right. And speaking of those spikes, to raise another quote,
- 10:45Speaker 1: Even a type 1 diabetic that doesn't produce insulin, they
- 10:49Speaker 1: have to take it. They have to inject themselves. Their
- 10:53Speaker 1: goal is to use the least amount of insulin possible
- 10:56Speaker 1: because the more insulin they have, the more side effects
- 10:59Speaker 1: they are going to get. Can you explain that to
- 11:01Speaker 1: our audience and why it's relevant?
- 11:03Speaker 2: Sure. This quote is spot on about how insulin can
- 11:07Speaker 2: have its own set of problems. It drives home the
- 11:10Speaker 2: point that even in the absence of self-produced insulin, The
- 11:13Speaker 2: goal remains to minimize its usage to avoid side effects.
- 11:17Speaker 2: For non-diabetics, reducing insulin levels can prevent these side effects
- 11:21Speaker 2: from occurring in the first place. It's a cautionary tale
- 11:24Speaker 2: about going too far with insulin and why we should
- 11:27Speaker 2: aim for balanced low levels.
- 11:28Speaker 1: That's profound. Now, let's look at the health risks associated
- 11:32Speaker 1: with high insulin levels from the next quote. You start
- 11:35Speaker 1: developing all sorts of problems in your arteries. High blood pressure,
- 11:39Speaker 1: problems with the eyes, the nerves, the heart. This sounds scary.
- 11:45Speaker 1: How can this impact our listeners directly?
- 11:47Speaker 2: Indeed, it's a scary scenario. High insulin levels contribute to
- 11:52Speaker 2: a cascade of health issues that can affect the entire body.
- 11:55Speaker 2: Arterial damage, hypertension, and cardiovascular issues are just the tip
- 12:00Speaker 2: of the iceberg. It reminds us that managing insulin levels
- 12:03Speaker 2: is crucial because it's not just a local problem, it's
- 12:07Speaker 2: a systemic one. Each of those issues can seriously affect
- 12:11Speaker 2: quality of life and longevity.
- 12:13Speaker 1: Agreed. Let's transition to the future research directions and technological
- 12:18Speaker 1: advancements you mentioned. Could we discuss how digital health solutions
- 12:23Speaker 1: could play a role in this, Thomas?
- 12:26Speaker 2: Absolutely. Digital health solutions offer a lifeline by providing real-time
- 12:31Speaker 2: data and personalized insights. Think of an app that could
- 12:35Speaker 2: monitor fasting insulin levels and recommend lifestyle changes. This kind
- 12:40Speaker 2: of technology could adjust based on genetic profiles, real-time data,
- 12:45Speaker 2: and personalized analytics to keep insulin levels in a healthy range.
- 12:49Speaker 2: It's all about moving from treating the symptoms to preventing
- 12:52Speaker 2: the causes.
- 12:53Speaker 1: That's exciting. And what about the role of personalization in
- 12:57Speaker 1: this technological future? How can genetic and epigenetic factors influence
- 13:03Speaker 1: these apps and solutions?
- 13:05Speaker 2: Genetic and epigenetic factors are key. They can help tailor
- 13:08Speaker 2: wellness plans that are specific to an individual's unique biology.
- 13:13Speaker 2: By integrating these factors, we can predict how someone might
- 13:16Speaker 2: respond to certain lifestyle changes or dietary adjustments. This personalized
- 13:21Speaker 2: approach could be revolutionary, allowing for more targeted and effective interventions.
- 13:26Speaker 1: Definitely. And on a broader scale, how do you see
- 13:29Speaker 1: the integration of these digital health solutions interacting with current
- 13:33Speaker 1: lab testing protocols.
- 13:34Speaker 2: With the integration, we could see more standardized and precise
- 13:38Speaker 2: testing methods. Labs could use more advanced technologies to provide
- 13:42Speaker 2: reliable results, reducing discrepancies and improving the accuracy of diagnostics.
- 13:49Speaker 2: This would be a huge step forward, ensuring that everyone
- 13:52Speaker 2: gets the most accurate and actionable information.
- 13:55Speaker 1: Speaking of which, let's dive into the integration of digital
- 13:58Speaker 1: health tools and genetic insights. How do you foresee these
- 14:02Speaker 1: technologies shaping the future of preventing and managing diabetes?
- 14:07Speaker 2: Thomas. Great question, Rachel. With the rise of wearable tech
- 14:11Speaker 2: and apps, individuals can track their glucose levels, monitor vital signs,
- 14:16Speaker 2: and even analyze genetic data to identify risk factors. For instance,
- 14:21Speaker 2: the continuous glucose monitoring systems can provide real-time data, allowing
- 14:26Speaker 2: for quicker interventions and better management of blood sugar levels.
- 14:30Speaker 2: And speaking of genetic insights, tools like genetic testing can
- 14:34Speaker 2: reveal polymorphisms that predispose individuals to insulin resistance, opening up
- 14:39Speaker 2: personalized prevention strategies.
- 14:41Speaker 1: Exactly. Those genetic markers are crucial. But how do you
- 14:45Speaker 1: think standardized diagnostic tools will play into this equation? After all,
- 14:50Speaker 1: we have seen variability in fasting insulin levels across different
- 14:54Speaker 1: regions and laboratory discrepancies.
- 14:56Speaker 2: That's the million-dollar question, and a valid one. Standardized diagnostic
- 15:01Speaker 2: tools would help ensure that everyone gets consistent, reliable results.
- 15:06Speaker 2: For example, labs could adopt next-generation sequencing for more precise
- 15:11Speaker 2: genetic analyses. Also, the implementation of AI in diagnostics could
- 15:16Speaker 2: streamline data interpretation, reducing errors and biases. It would be
- 15:21Speaker 2: a step forward in making healthcare more equitable and effective.
- 15:24Speaker 1: Right. And that's the crucial nuance here. In practice, though,
- 15:29Speaker 1: We need more than just tools. We need to establish
- 15:32Speaker 1: clear protocols and standards. What do you think should be
- 15:36Speaker 1: the next steps in achieving this?
- 15:38Speaker 2: I agree, Rachel. First, we need to establish a consensus
- 15:42Speaker 2: on reference ranges for fasting insulin levels. This could involve
- 15:46Speaker 2: bringing together experts from various regions to discuss and standardize benchmarks. Second,
- 15:52Speaker 2: we should focus on the integration of digital health platforms
- 15:54Speaker 2: with diagnostic tools. This would enable seamless tracking of patient data,
- 15:59Speaker 2: providing a comprehensive view of their health status.
- 16:02Speaker 1: That sounds like a practical approach. And let's not forget
- 16:06Speaker 1: the importance of a personalized wellness plan. How do you
- 16:09Speaker 1: see these digital tools facilitating that?
- 16:12Speaker 2: Absolutely. Personalized plans could be generated based on genetic insights,
- 16:17Speaker 2: lifestyle data, and real-time health metrics. For instance, a person
- 16:22Speaker 2: with a specific genetic marker for insulin resistance could be
- 16:25Speaker 2: advised to focus on certain dietary changes and exercise routines.
- 16:30Speaker 2: This personalized approach could be revolutionary, allowing for more targeted
- 16:34Speaker 2: and effective interventions.
- 16:35Speaker 1: Right. And this would certainly improve adherence to treatment plans.
- 16:41Speaker 1: Speaking of adherence, how do you think these technologies can
- 16:44Speaker 1: help address compliance issues?
- 16:46Speaker 2: Great point. By providing real-time feedback and personalized recommendations, These
- 16:52Speaker 2: tools can enhance patient engagement and motivation. For example, an
- 16:57Speaker 2: app could send reminders, track progress, and offer rewards for
- 17:01Speaker 2: meeting goals. This would not only improve compliance but also
- 17:06Speaker 2: make the process more enjoyable and less overwhelming.
- 17:09Speaker 1: Absolutely. And it's exciting to think about the future where
- 17:14Speaker 1: these technologies could completely transform diabetes management. It's quite a
- 17:19Speaker 1: leap from where we are now.
- 17:20Speaker 2: Indeed, it's a leap that could save countless lives. The
- 17:24Speaker 2: key is to continue pushing the boundaries of what's possible
- 17:28Speaker 2: while ensuring we don't lose sight of the human element
- 17:31Speaker 2: in healthcare.
- 17:31Speaker 1: That brings us to the end of today's episode. Thank
- 17:34Speaker 1: you so much for spending part of your day with me.
- 17:37Speaker 1: If you found this episode's tips helpful and want to
- 17:40Speaker 1: make sure you don't miss the next conversation, please take
- 17:43Speaker 1: a quick second to hit that subscribe or follow button.
- 17:46Speaker 1: on whatever platform you are listening on. It's a completely
- 17:50Speaker 1: free way to support the show and helps more people
- 17:53Speaker 1: find us. This podcast is independently produced, so if you
- 17:57Speaker 1: are ever in a position where you would like to
- 17:58Speaker 1: help keep it running, we do accept small donations. You
- 18:02Speaker 1: can find a link right in the episode description below
- 18:05Speaker 1: to buy us a coffee or contribute what you can.
- 18:08Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 18:12Speaker 1: and we will talk again soon.